435 related articles for article (PubMed ID: 24038116)
1. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.
Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116
[TBL] [Abstract][Full Text] [Related]
2. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
Pind ML; Bendtsen F; Kallemose T; Møller S
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis.
Berzigotti A; Gilabert R; Abraldes JG; Nicolau C; Bru C; Bosch J; García-Pagan JC
Am J Gastroenterol; 2008 May; 103(5):1159-67. PubMed ID: 18477345
[TBL] [Abstract][Full Text] [Related]
5. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
6. The indocyanine green retention test as a noninvasive marker for esophageal varices in patients with hepatocellular carcinoma.
Lu HS; Hsin IF; Chen PH; Yang TC; Chang CY; Huang YH; Hou MC
J Chin Med Assoc; 2020 Aug; 83(8):737-742. PubMed ID: 32649412
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
[TBL] [Abstract][Full Text] [Related]
8. Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.
Møller S; la Cour Sibbesen E; Madsen JL; Bendtsen F
J Gastroenterol Hepatol; 2019 Jun; 34(6):1093-1099. PubMed ID: 30221390
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of indocyanine green retention test and indocyanine green clearance in Child-Pugh class A patients.
Pind ML; Møller S; Faqir N; Bendtsen F
Hepatology; 2015 Jun; 61(6):2112-3. PubMed ID: 25330382
[No Abstract] [Full Text] [Related]
11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
13. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.
Vizzutti F; Arena U; Romanelli RG; Rega L; Foschi M; Colagrande S; Petrarca A; Moscarella S; Belli G; Zignego AL; Marra F; Laffi G; Pinzani M
Hepatology; 2007 May; 45(5):1290-7. PubMed ID: 17464971
[TBL] [Abstract][Full Text] [Related]
14. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?
Hassan EM; Omran DA; El Beshlawey ML; Abdo M; El Askary A
Gastroenterol Hepatol; 2014 Feb; 37(2):58-65. PubMed ID: 24365388
[TBL] [Abstract][Full Text] [Related]
15. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
Colecchia A; Montrone L; Scaioli E; Bacchi-Reggiani ML; Colli A; Casazza G; Schiumerini R; Turco L; Di Biase AR; Mazzella G; Marzi L; Arena U; Pinzani M; Festi D
Gastroenterology; 2012 Sep; 143(3):646-654. PubMed ID: 22643348
[TBL] [Abstract][Full Text] [Related]
16. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
Jiang FR; Yan HD
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
[No Abstract] [Full Text] [Related]
18. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.
Procopet B; Cristea VM; Robic MA; Grigorescu M; Agachi PS; Metivier S; Peron JM; Selves J; Stefanescu H; Berzigotti A; Vinel JP; Bureau C
Dig Liver Dis; 2015 May; 47(5):411-6. PubMed ID: 25732434
[TBL] [Abstract][Full Text] [Related]
19. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
Wang L; Feng Y; Ma X; Wang G; Wu H; Xie X; Zhang C; Zhu Q
PLoS One; 2017; 12(8):e0182969. PubMed ID: 28820885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
